Joan Genescà Ferrer Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine. Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Twitter Orcid Joan Genescà Ferrer Twitter Orcid Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.
Projects De la sencillez en el diagnóstico (no masivo) y seguimiento de la enfermedad hepática crónica avanzada a los complejos mecanismos terapéuticos de las estatinas en modelos animales. IP: Joan Genescà Ferrer Collaborators: Immaculada Raurell Saborit, Ares Aurora Villagrasa Vilella, Mònica Pons Delgado Funding agency: Instituto de Salud Carlos III Funding: 196020 Reference: PI18/00947 Duration: 01/01/2019 - 30/06/2023 DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEM APPROACHES IP: Joan Genescà Ferrer Collaborators: DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEM APPROACHES Funding agency: EUROPEAN COMMISSION Funding: 130472.5 Reference: DECISION_H2020-SC1-BHC2019 Duration: 01/04/2020 - 30/09/2025 Enfermedades hepáticas-Enfermedad crónica hepática avanzada y sus complicaciones. IP: Joan Genescà Ferrer Collaborators: Mònica Pons Delgado, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 53732 Reference: CM18/00061 Duration: 01/01/2019 - 20/09/2021 EU Patient- cEntric clinicAl tRial pLatform - EU PEARL. IP: Joan Genescà Ferrer Collaborators: Santiago Pérez Hoyos, Anna Sanjuan Viaplana, Xavier Cañas Perea, Juan Espinosa Pereiro, Juan Manuel Pericàs Pulido, José Antonio Ramos Quiroga, Israel Molina Romero, Alex Sánchez Pla, Inmaculada Fuentes Camps, Adrián Sánchez Montalvá, Pol Ibañez Jimenez, Olga Sánchez- Maroto Carrizo, Gara Arteaga Henriquez, Alba Maria Jiménez Masip, Albert Barberà LLuis Funding agency: The Innovative Medicines Initiative Funding: 1987375 Reference: EU-PEARL_H2020_IMI2-2018 Duration: 01/11/2019 - 30/04/2023 Pagination First page « Previous page ‹ … Page 2 Page 3 Current page 4 Page 5 Page 6 … Next page › Last page »
